Ketamine in neuropsychiatric disorders: an update.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology January 2024 Jenessa N Johnston, Bashkim Kadriu, Christoph Kraus et al.
The discovery of ketamine as a rapid-acting antidepressant led to a new era in the development of neuropsychiatric therapeutics, one characterized by an antidepressant response that occurred within hours or days rather than weeks or months. Considerable clinical research supports the use of-or further research with-subanesthetic-dose ketamine and its (S)-enantiomer esketamine in multiple...